KROS Operating Expenses

Keros Therapeutics Inc · Operating Expenses

KROS logo

KROS Operating Expenses

Latest reported$115.68M
KROS TTM Operating Expenses ($20.56M → $115.68M)
High-resolution chart · PNG

KROS operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Keros Therapeutics Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
115,684,000
142,362,000
175,727,000
202,036,000
231,516,000
224,377,000
213,737,000
204,371,000
188,377,000
179,238,000
169,541,000
154,903,000
140,142,000
129,533,000
114,790,000
107,394,000
99,615,000
74,545,000
66,188,000
54,915,000
46,666,000
51,922,000
46,657,000
38,594,000
31,472,000
25,709,000
20,563,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.